Industry top-down
Medical Instruments & Supplies
Latest reported revenue & EPS across the covered companies in this industry, with year-over-year (YoY) change. From disclosed earnings — not investment advice.
AI industry top-down
The medical device and supplies industry showed a mixed trend, with significant performance disparities among companies. Some companies demonstrated solid growth, achieving double-digit revenue growth rates and high EPS growth rates. Conversely, other companies experienced negative growth, with both revenue and EPS decreasing. The industry's median revenue growth rate was 3.55%, indicating a moderate overall growth trend but with significant disparities in individual company performance.
- Strong revenue and EPS growth for some companies
- Revenue and EPS decline for some companies
- Moderate industry-wide revenue growth rate at 3.55%
AI synthesis of disclosed results and analyst research across these companies — not investment advice.
Companies — latest quarter
| Company | Period | Revenue | Rev YoY | EPS | EPS YoY | Surprise |
|---|---|---|---|---|---|---|
| ISRGINTUITIVE SURGICAL INC | FY2026 Q1 | $2.25B | +19.2% | $1.92 | +27.2% | — |
| BDXBECTON DICKINSON & CO | FY2026 Q2 | $8.81B | -9.6% | $2.11 | -24.9% | — |
| MDLNMedline Inc. | FY2026 Q1 | $6.64B | — | $0.16 | — | — |
| ALGNALIGN TECHNOLOGY INC | FY2026 Q1 | $979.26M | -1.8% | $1.27 | -8.6% | — |
| COOCOOPER COMPANIES, INC. | FY2026 Q1 | $964.7M | +3.6% | $0.52 | +26.8% | — |
| BAXBAXTER INTERNATIONAL INC | FY2026 Q1 | $2.63B | +5.4% | $0.25 | +257.1% | — |
| ATRAPTARGROUP, INC. | FY2026 Q1 | $887.31M | -3.1% | $1.17 | -4.9% | — |
| AVTRAvantor, Inc. | FY2026 Q1 | $1.58B | -5.9% | $0.09 | 0.0% | — |
| BLCOBausch & Lomb Corp | FY2026 Q1 | $1.14B | +3.5% | $-0.60 | — | — |
| NVSTEnvista Holdings Corp | FY2026 Q1 | $616.9M | -1.1% | $0.10 | -28.6% | — |
| MMSIMERIT MEDICAL SYSTEMS INC | FY2026 Q1 | $355.35M | +9.8% | $0.49 | +2.1% | — |
| ICUIICU MEDICAL INC/DE | FY2026 Q1 | $604.7M | +6.7% | $-0.63 | — | — |
| MMEDMiniMed Group, Inc. | FY2026 Q3 | $1.99B | — | $-0.16 | — | — |
| LMATLEMAITRE VASCULAR INC | FY2024 Q3 | $144.6M | +19.8% | $0.97 | +42.6% | — |
| PLSEPULSE BIOSCIENCES, INC. | FY2022 Q3 | $574K | — | $-1.76 | — | — |
| ATRCAtriCure, Inc. | FY2026 Q1 | $123.62M | +13.6% | $-0.14 | — | — |
| KMTSKESTRA MEDICAL TECHNOLOGIES, LTD. | FY2026 Q3 | $42.58M | — | $-3.56 | — | — |
| AZTAAzenta, Inc. | FY2026 Q2 | $290.77M | +4.6% | $-1.29 | — | — |
| AVRAnteris Technologies Global Corp. | FY2026 Q1 | $556K | -27.4% | $-0.61 | — | — |
| ANGOANGIODYNAMICS INC | FY2026 Q3 | $212.34M | -8.8% | $-0.68 | — | — |
| OSURORASURE TECHNOLOGIES INC | FY2026 Q1 | $29.93M | -44.7% | $-0.21 | — | — |
| PDEXPRO DEX INC | FY2026 Q3 | $49.1M | +26.5% | $2.31 | — | — |
YoY = vs. the same quarter last year · Surprise = EPS actual vs. consensus. Latest reported quarter per company, from disclosed earnings filings. QoQ is omitted because quarterly filings don’t break out Q4 (US) and report cumulatively (KR).